a) New tracer development: Pyruvic acid is the only tracer approved for human studies. We have optimized conditions for polarization in the human polarizer as well as in pre-clinical polarizer/scanner and are routinely using in ongoing research with several models such as: i) LDHAi studies monitoring the lactate/pyruvate as a pharmacodynamics imaging biomarker to help in lead compound identification; ii) monitoring the bioenergetics profiles of prostate cancer xenografts, orthotopic glioblastoma, and pancreatic cancer xenografts and testing the imaging biomarker response to treatments. While these studies are ongoing, we are developing new tracers such as variants of a-ketoglutarate, dimethyl ketoglutarate, esters of succinate. Polarization conditions for these new agents and preliminary in vivo data have been generated. b) In Vitro system to study metabolic flux data: Several tumor cell lines exist for which xenograft models are not feasible. TO study their metabolic profile, an in cell system has been developed and implemented for in vitro studies in cellular incubations with hyperpolarized substrates such as pyruvate, a-ketoglutarate, succinate esters. An NMR bioreactor comprised of a 5 mm NMR tube in a closed loop, with an injection port to receive hyperpolarized substrates with a perfusion system maintained at physiological temperatures in a table top NMR spectrometer has been assembled. Cells are grown in microcarriers to achieve high cell density and in viable conditions are established. Routine experiments are underway. c) De-noising spectral data from metabolic MRI: With hyperpolarization, the sensitivity gap of 4 orders in magnitude has been achieved to enable 13C Magnetic Resonance Spectroscopic Imaging to monitor the metabolic/biochemical profile of tissues. However, any additional gain in sensitivity by post processing of the acquired data is immensely helpful in improving image quality and also identify and quantify low level metabolic fluxes. A de-noising scheme of spectral data using rank matrix reduction and linear prediction has been developed and significant sensitivity enhancement has been realized. This numerical method can be incorporated in pre-clinical and clinical imaging as well as in NMR based metabolomics. d) Clinical Imaging. i) GMP training: One member in RBB has been trained for GMP operations and has received certification. This will be needed for the tracer compounding in clean room for patient studies. A NIH/CC pharmacist and associate have been involved in this and this team of three will be involved in production of clinical doses. ii) RF Coils: We have identified commercial sources for RF coils for torso, head, and prostate imaging and have placed orders and expect them to be delivered within 60 days. ii) Pulse Programs: We have integrated pulse programs needed for 13C MRI with the conventional 1H based anatomic imaging sequences. We have tested them using phantom objects and with experimental animals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIABC010477-14
Application #
9343626
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
Read, Graham H; Miura, Natsuko; Carter, Jenna L et al. (2018) Three-dimensional alginate hydrogels for radiobiological and metabolic studies of cancer cells. Colloids Surf B Biointerfaces 171:197-204
Matsumoto, Ken-Ichiro; Mitchell, James B; Krishna, Murali C (2018) Comparative studies with EPR and MRI on the in vivo tissue redox status estimation using redox-sensitive nitroxyl probes: influence of the choice of the region of interest. Free Radic Res 52:248-255
Kishimoto, Shun; Bernardo, Marcelino; Saito, Keita et al. (2015) Evaluation of oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy using IR-700-antibody conjugates. Free Radic Biol Med 85:24-32
Enomoto, Ayano; Hirata, Hiroshi; Matsumoto, Shingo et al. (2014) Four-channel surface coil array for 300-MHz pulsed EPR imaging: proof-of-concept experiments. Magn Reson Med 71:853-8
Jang, Hyungseok; Subramanian, Sankaran; Devasahayam, Nallathamby et al. (2013) Single acquisition quantitative single-point electron paramagnetic resonance imaging. Magn Reson Med 70:1173-81
Krishna, Murali C; Matsumoto, Shingo; Saito, Keita et al. (2013) Magnetic resonance imaging of tumor oxygenation and metabolic profile. Acta Oncol 52:1248-56
Matsumoto, Shingo; Saito, Keita; Yasui, Hironobu et al. (2013) EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate. Magn Reson Med 69:1443-50
Matsumoto, Shingo; Batra, Sonny; Saito, Keita et al. (2011) Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia. Cancer Res 71:6350-9
Day, Sam E; Kettunen, Mikko I; Cherukuri, Murali Krishna et al. (2011) Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imaging. Magn Reson Med 65:557-63